Wybranowski, T.; Pyskir, J.; Bosek, M.; Napiórkowska, M.; Cyrankiewicz, M.; Ziomkowska, B.; Pilaczyńska-Cemel, M.; Pyskir, M.; Rogańska, M.; Kruszewski, S.;
et al. The Mortality Risk and Pulmonary Fibrosis Investigated by Time-Resolved Fluorescence Spectroscopy from Plasma in COVID-19 Patients. J. Clin. Med. 2022, 11, 5081.
https://doi.org/10.3390/jcm11175081
AMA Style
Wybranowski T, Pyskir J, Bosek M, Napiórkowska M, Cyrankiewicz M, Ziomkowska B, Pilaczyńska-Cemel M, Pyskir M, Rogańska M, Kruszewski S,
et al. The Mortality Risk and Pulmonary Fibrosis Investigated by Time-Resolved Fluorescence Spectroscopy from Plasma in COVID-19 Patients. Journal of Clinical Medicine. 2022; 11(17):5081.
https://doi.org/10.3390/jcm11175081
Chicago/Turabian Style
Wybranowski, Tomasz, Jerzy Pyskir, Maciej Bosek, Marta Napiórkowska, Michał Cyrankiewicz, Blanka Ziomkowska, Marta Pilaczyńska-Cemel, Małgorzata Pyskir, Milena Rogańska, Stefan Kruszewski,
and et al. 2022. "The Mortality Risk and Pulmonary Fibrosis Investigated by Time-Resolved Fluorescence Spectroscopy from Plasma in COVID-19 Patients" Journal of Clinical Medicine 11, no. 17: 5081.
https://doi.org/10.3390/jcm11175081
APA Style
Wybranowski, T., Pyskir, J., Bosek, M., Napiórkowska, M., Cyrankiewicz, M., Ziomkowska, B., Pilaczyńska-Cemel, M., Pyskir, M., Rogańska, M., Kruszewski, S., & Przybylski, G.
(2022). The Mortality Risk and Pulmonary Fibrosis Investigated by Time-Resolved Fluorescence Spectroscopy from Plasma in COVID-19 Patients. Journal of Clinical Medicine, 11(17), 5081.
https://doi.org/10.3390/jcm11175081
